Leading innovation in Immunology research

Bristol Myers Squibb has a long legacy of innovation. Throughout the company’s history, scientific breakthroughs have fundamentally changed research and treatment approaches, providing the potential to transform the lives of patients with high unmet needs.

Pulmonary fibrosis is a chronic, life-threatening interstitial lung disease (ILD) that occurs when lung tissue becomes damaged and scarred, impairing lung function and resulting in daily symptoms such as chronic cough, extreme breathlessness and severe fatigue often experienced after exercise, household activities or social activities. 

At Bristol Myers Squibb, we strive to go beyond the incremental in our research and development efforts for immune-mediated diseases such as lupus. Hear perspectives from Francisco Ramírez-Valle, MD, PhD, and Alyssa Johnsen, MD, PhD, on how our scientists are advancing lupus research across the disease spectrum.